Anti-inflammatory and analgesic activities of stem bark extracts of Eugenia jambolana
- 1*,
- 2,
- 2
- 1P. G. Department of Studies and Research in Biotechnology and Bioinformatics, Kuvempu University, Shankaraghatta, Karnataka, India.
- 2Department of Biotechnology, Manipal Life Science Center, Manipal University, Manipal, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Sudeep V. Hegde
P. G. Department of Studies and Research in Biotechnology and Bioinformatics, Kuvempu University, Shankaraghatta, Karnataka, India.
Email: sudeepkashyap.82@gmail.com
Copyright: © 2011 The Author(s). This is an open access article.
Abstract
The world is facing an explosive increase in the incidence of many systemic diseases and hence cost effective complementary therapies are needed. Medicinal plants have been the subject of intense research due to their potential as sources of commercial drugs or as lead compounds in drug development. The drugs which are used presently for the management of pain and infl ammatory conditions are either narcotics or non narcotics (NSAIDS), and have known toxic and lethal effects. On the contrary, herbal medicines with good absorption, less toxicity, and easy availability have been used since ancient times. It is therefore,essential that efforts be made to introduce new medicinal plants, to develop cheaper and effective drugs. Eugenia jambolana Lam. (Myrtaceae) has been claimed to reduce different ailments in the folk medicine. We have investigated the anti-infl ammatory and analgesic activities of petroleum ether, ethyl acetate, and methanol extracts of E. jambolana stem bark.
Subject
Readers Also Viewed
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei
Jan 1, 2025
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026